Beijing Science Sun Pharmaceutical Hits Day Low Amid Price Pressure at CNY 9.72

Beijing Science Sun Pharmaceutical Co., Ltd. experienced a notable decline today, with its stock price dropping by 7.47% to reach an intraday low of CNY 9.72. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Beijing Science Sun has seen a more significant downturn, with a 10.84% decrease, and a 13.06% decline over the past month. Despite these recent challenges, the company has shown a positive return of 33.74% over the past year, outperforming the China Shanghai Composite's 13.33% gain. Financial metrics indicate that the company is facing difficulties, with a low Return on Capital Employed (ROCE) of 2.69% and a concerning trend in net sales, which have decreased at an annual rate of 18.31% over the last five years. The operating profit margin has also reached a low of -10.45%, reflecting ongoing financial pressures. As a small-cap player in the Pharmaceuticals & Biotechnology sector, Beijing Science Sun's market capitalization stands at CNY 2,853 million, with a Price to Book ratio of 0.84.